Pharma has a key role to play in helping cancer specialists meet their professional development requirements – and a new digital platform could help that partnership grow further.
The Private Cancer Physicians of Australia (PCPA) has announced the launch of a new digital platform, CPD4MedProfessional.com, which will help cancer specialists meet their updated continuing professional development (CPD) requirements.
The new online support program has been developed with the PCPA’s education partners ScienceToLife.
https://www.pcpa.org.au/wp-content/uploads/2021/03/favicon-pcpa.png540540Jerry Liuhttps://www.pcpa.org.au/wp-content/uploads/2025/12/logo-pcpa-colour-reversed.svgJerry Liu2023-07-03 16:42:272023-07-03 16:42:27PCPA in the news – New platform for oncologist MedEd
Antibody-drug conjugates (ADCs), described as “biological missiles” and “smart bombs” against cancer, could have the potential to replace chemotherapy for metastatic breast cancer.
Speaking on the Private Cancer Physicians of Australia Podcast series, University of California San Francisco Director of Breast Oncology Professor Hope Rugo said the precise and potent surface-antibody drugs were proving effective and better tolerated than existing treatments.
“This is such an exciting topic for all of us,” Rugo said. “It pervades everything […]
https://www.pcpa.org.au/wp-content/uploads/2021/03/favicon-pcpa.png540540Jerry Liuhttps://www.pcpa.org.au/wp-content/uploads/2025/12/logo-pcpa-colour-reversed.svgJerry Liu2023-06-19 12:19:552023-06-19 12:20:44PCPA in the news – can ‘smart bombs’ replace chemo?
PCPA in the news – New platform for oncologist MedEd
/in News, PCPA in the news /by Jerry Liupharma in focus 19 June – 23 June 2023
Posted 21 June 2023
Pharma has a key role to play in helping cancer specialists meet their professional development requirements – and a new digital platform could help that partnership grow further.
The Private Cancer Physicians of Australia (PCPA) has announced the launch of a new digital platform, CPD4MedProfessional.com, which will help cancer specialists meet their updated continuing professional development (CPD) requirements.
The new online support program has been developed with the PCPA’s education partners ScienceToLife.
Currently seven pharma […]
PCPA Media Release – Friday 30 June 2023
/in Media Releases /by Jerry LiuPCPA in the news – can ‘smart bombs’ replace chemo?
/in News, PCPA in the news /by Jerry Liupharma in focus 13 June – 16 June 2023
Posted 15 June 2023
Antibody-drug conjugates (ADCs), described as “biological missiles” and “smart bombs” against cancer, could have the potential to replace chemotherapy for metastatic breast cancer.
Speaking on the Private Cancer Physicians of Australia Podcast series, University of California San Francisco Director of Breast Oncology Professor Hope Rugo said the precise and potent surface-antibody drugs were proving effective and better tolerated than existing treatments.
“This is such an exciting topic for all of us,” Rugo said. “It pervades everything […]